Citation Tools

Download PDFPDF

289 PGV-001: a phase 1 trial of a personalized neoantigen peptide vaccine for the treatment of malignancies in the adjuvant setting

Download to a citation manager

Cite this article as:
Marron T, Kodysh J, Rubinsteyn A, et al
289 PGV-001: a phase 1 trial of a personalized neoantigen peptide vaccine for the treatment of malignancies in the adjuvant setting